Registration Now Open for BOS Events 2024!

Bio2Business Ltd is delighted to open registration for BOS Events 2024 which includes: BOS Basel 2024, which will take place on the 19th and 20th of June at Congress Centre Basel; and BOS Manchester 2024, which will take place on the 26th and 27th of November at Manchester Central.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for virtual events during 2024. We look forward to welcoming you and your colleagues to BOS Events 2024! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Basel 2023)

Logo for Ardena Holding NV
Ardena Holding NV
We are a fully-integrated pharmaceutical CDMO that guides companies through the drug development process to help create effective and compliant drug products for clinical trials, supporting small molecule, peptide and nanomedicine therapeutics. Our drug development support includes (pre-IND through...
View profile

Featured Speaker (BOS Basel 2023)

photo of Mr Mr Matthew McLoughlin

Revolutionising Procurement: Go from Reactive to Proactive

Mr Matthew McLoughlin, Senior Vice President, Scientist.com

ABSTRACT: The challenges faced when outsourcing CMC services have evolved over the past few years. The pandemic's impact has resulted in research organisations no longer wanting to consolidate the sources of their CMC services in a single location; instead, they prefer quick and easy access to local suppliers to ensure a consistent supply chain. Equally, the demand for accessing new and innovative technologies, such as Direct Powder Extrusion (DPE) 3D printing, for instance, as well as suppliers, also presents challenges to ensuring these companies meet quality requirements and internal standards and policies.... Click here to Read More